Ruqayyah Snyder
DMHA, or Octodrine, is a synthetic stimulant compound with effects similar to DMAA, which is banned by many sports organisations and governments due to safety concerns. DMHA was banned in Australia in 2012, and since then, several replacement stimulants have been found and subsequently banned as well. DMHA was banned for OTC purchase in Australia from 1 October 2017, and is classified as a schedule 10 drug that requires a security clearance prescription. The ban was implemented by Australia's Therapeutic Goods Administration (TGA) due to the dangers DMHA poses to human health, including potential cardiac, nervous, and psychiatric disorders.
| Characteristics | Values |
|---|---|
| Date of Ban | 1 October 2017 |
| Type of Drug | Stimulant |
| Other Names | Octodrine, 2-Aminoisoheptane |
| Structure | Similar to DMAA and nasal decongestant drug tuaminoheptane |
| Side Effects | May cause heart attack, death, cardiac, nervous and psychiatric disorders, increased heart rate and high blood pressure |
| Use | Used for athletic performance, obesity and other conditions |
| Safety | Possibly unsafe |
| Legality | Illegal for importation without an import permit |
| Availability | Available with a Schedule 10 prescription |
Explore related products
What You'll Learn
DMHA is a strong stimulant
DMHA, or Octodrine, is a strong synthetic stimulant compound that is similar to DMAA and AMP Citrate. DMHA boosts energy levels, focus, concentration and suppresses appetite. It is also said to elicit a feeling of euphoria. DMHA was a popular ingredient in pre-workout and fat-burning supplements.
DMHA is a stimulant that can speed up the nervous system. This can lead to an increased heart rate and high blood pressure. It is advised that DMHA should not be taken with other stimulant drugs as it may cause serious problems, including an increased heart rate and high blood pressure. It may also cause side effects similar to DMAA, including heart attack and death. Due to these safety concerns, DMHA has been banned by many sports organisations and governments.
DMHA was banned in Australia in 2012, and since then, companies have been searching for replacement ingredients. In 2017, Australia's Therapeutic Goods Administration (TGA) announced that products containing DMHA would no longer be available for sale in Australia. The TGA stated that the sale, supply, and use of products containing DMHA are prohibited due to the dangers they pose to human health, including cardiac, nervous, and psychiatric disorders.
DMHA is classified as a Schedule 10 drug in Australia, which requires a security clearance prescription. It is illegal to import without an import permit. Some alternatives to DMHA include Teacrine, Dynamine, and Higenamine HCL.
John Wayne's Australian Adventure: Did He Fly There?
You may want to see also
Explore related products
![NatureWise Curcumin Turmeric 2250mg - 95% Curcuminoids & BioPerine Black Pepper Extract for Advanced Absorption - Daily Joint and Immune Health Support - Vegan, Non-GMO, 180 Count[60-Day Supply]](https://m.media-amazon.com/images/I/714UFxWRUFL._AC_UL320_.jpg)
DMHA is linked to cardiac, nervous and psychiatric disorders
DMHA, or dimethylhexylamine, is a stimulant similar to dimethylamylamine (DMAA), which has been banned by many sports organisations and governments due to safety concerns. DMHA is also considered unsafe and has been linked to several cardiac, nervous, and psychiatric disorders.
Firstly, DMHA has been associated with an increased risk of cardiac problems. It has stimulant effects, which can lead to an increased heart rate and high blood pressure. This could be particularly dangerous for individuals with pre-existing heart conditions, such as irregular heartbeat or heart arrhythmia, as DMHA may worsen these conditions. Additionally, taking DMHA with other stimulant drugs could cause serious problems, including a further increased heart rate and elevated blood pressure.
Secondly, as a stimulant, DMHA can speed up the nervous system, leading to potential nervous system disorders. It may also interfere with certain surgical procedures by increasing the heart rate and blood pressure to unsafe levels.
Lastly, regarding psychiatric disorders, DMHA has been linked to severe side effects, including the risk of heart attack and death. It is important to note that there is limited research on the safety of DMHA, and it is currently not approved for human consumption in some countries, including the United States.
Due to these potential risks, DMHA was banned in Australia in 2012. It is important for individuals to carefully consider the potential risks associated with DMHA and consult healthcare professionals before use.
Snickers: Australian-Made or Imported?
You may want to see also
Explore related products
DMHA is banned for OTC purchase in Australia
DMHA, or Octodrine, is a synthetic compound with effects similar to DMAA, which boosts energy levels, focus, concentration and suppresses appetite. DMHA is a stimulant and nootropic, and users can experience increased alertness, energy, and mood enhancement.
DMHA was banned in Australia in 2012, and since then, companies have been looking for replacement ingredients. In 2017, Australia's Therapeutic Goods Administration (TGA) announced that products containing DMHA would no longer be available for sale in Australia. The sale, supply, and use of DMHA are prohibited in Australia due to the dangers they pose to human health. Potential adverse effects of DMHA include cardiac, nervous, and psychiatric disorders, and it may also cause side effects similar to DMAA, including heart attack and death.
DMHA is banned for over-the-counter (OTC) purchase in Australia as of October 1, 2017. It is classified as a Schedule 10 drug, which requires a security clearance prescription. It is illegal to import DMHA into Australia without an import permit.
Some alternatives to DMHA include Teacrine, Dynamine, and Higenamine HCL. Citrus aurantium, Hordenine, and Caffeine are also alternatives, although they are not as powerful as the primary alternatives.
Kraft Peanut Butter: Australian-Made or Not?
You may want to see also
Explore related products
$21.5
DMHA is structurally similar to DMAA, which is banned in sports
DMHA, or Octodrine, is a synthetic compound with effects similar to those of DMAA. DMHA boosts energy levels, focus, concentration, and suppresses appetite. DMAA, or dimethylamylamine, is a stronger stimulant per milligram, with about two to three times the potency of DMHA. Both DMAA and DMHA can create feelings of energy, alertness, and euphoria.
DMHA and DMAA are structurally similar and are both banned by the World Anti-Doping Agency (WADA). They are not approved by the US Food and Drug Administration (FDA) for inclusion in dietary supplements. DMHA was banned in Australia in 2012, and DMAA was banned in New Zealand in 2012. The Australian government's Department of Health (Therapeutic Goods Administration) banned DMHA effective October 1, 2017, classifying it as a Schedule 10 drug requiring a security clearance prescription.
DMHA and DMAA are often listed under different names on product labels, possibly to avoid detection by regulatory bodies like the FDA. They are only found in the most "hardcore" supplements, and mainstream supplements do not include these ingredients.
DMHA and DMAA can be dangerous, with side effects including increased heart rate and blood pressure, rapid heartbeat, and interference with surgery. DMHA might cause side effects similar to DMAA, including heart attack and death. Due to these serious health risks, it is important that consumers are aware of the presence of these substances in products and that regulatory bodies are able to detect them.
Australian Government's War on Bees: What's the Buzz?
You may want to see also
Explore related products
DMHA is possibly unsafe for pregnant or breastfeeding women
DMHA, or Octodrine, is a synthetic stimulant compound with effects similar to those of DMAA, which boosts energy levels, focus, concentration and suppresses appetite. DMHA was banned in Australia in 2012, and subsequently classified as a Schedule 10 drug in 2017. This means that it requires a security clearance prescription and is illegal to import without a permit.
The potential risks of DMHA use during pregnancy and breastfeeding are unknown, and further research is needed to understand its safety profile for this population. In the absence of sufficient data and research, healthcare providers generally do not recommend the use of DMHA for pregnant or breastfeeding women.
It is important to note that the use of any supplement or medication during pregnancy and breastfeeding should be carefully considered and discussed with a healthcare provider. The potential risks and benefits must be weighed, and alternatives explored, to ensure the safety of both mother and child.
Overall, while the direct impact of DMHA on pregnant or breastfeeding women is uncertain, its classification as a strong stimulant and its potential effects on the body suggest that it is possibly unsafe for this vulnerable group.
Turquoise Gemstones: Australia's Top Mining Locations
You may want to see also
Frequently asked questions
DMHA is a strong stimulant that can increase energy, improve focus, and reduce appetite. However, it has been banned in Australia since 2017 due to safety concerns and the adverse effects it can have on human health, including cardiac, nervous, and psychiatric disorders.
DMHA, or Dimethylhexylamine, is a stimulant similar to Dimethylamylamine (DMAA), which is also banned in many countries due to safety concerns.
DMHA was commonly found in pre-workout supplements and fat burners.
DMHA was banned in Australia on October 1, 2017. It is classified as a Schedule 10 drug, which requires a prescription and security clearance.
Yes, there are several alternatives to DMHA, including Teacrine, Dynamine, and Higenamine HCL. These alternatives are powerful, safe, and legal.
